Artificial Intelligence | Machine Learning | Machine Perception Ultivue | Multiplexed Immuno-Profiling


Enterprise, Biotechnology, Pharmaceuticals, Diagnostics, Drug Discovery, Tissue Image Analysis Cambridge, MA, United States

Ultivue

Artificial Intelligence | Machine Learning | Machine Perception


Ultivue | Multiplexed Immuno-Profiling

Ultivue

Biotechnology, Pharmaceuticals, Diagnostics, Drug Discovery, Tissue Image Analysis


Cambridge, MA, United States

Ultivue provides researchers and scientists with multiplex biomarker assays for tissue phenotyping and digital pathology. Our proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research. Our highly customizable solutions and scientific consultative approach strengthen and accelerate biomarker discovery and drug development programs.

Ultivue develops innovative reagent-based solutions that maximize the biological information available from cells and tissue samples. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand biology and medicine. Ultivue's products are designed for fluorescent microscopy-based research and will eventually be valuable for clinical diagnostic use. It was founded in 2015 and headquartered in Cambridge, Massachusetts.

 

B2B

51 to 100

Series D

$107.3 M

Scaling Up

2015

 
 

Healthcare
Biotechnology
Pharmaceuticals

N/A

Increase Efficiency

 
 

Service

Yes

Active

 
 

   Machine Learning
   Machine Perception


Biomarker Development

Biomarker Development

Drug Discovery

Drug Discovery

Medical Image Analysis

Medical Image Analysis


N/A

 

   Software


N/A


Machine Learning Algorithm

Machine Learning Algorithm

Image Algorithm

Image Algorithm

 
 

View All

Senior Scientist, Research

Cambridge, Massachusetts

Research Scientist

Cambridge, Massachusetts

Associate Scientist, Research

Cambridge, Massachusetts

Associate Scientist, Research

Cambridge, Massachusetts

Senior Director, Computational Pathology

Cambridge, Massachusetts

 

AI/ML Professionals

Want to work at Ultivue?

We can introduce you to the right person at Ultivue

Talk to our Talent Team

 

6

1

$50M

Company was founded 2015 and it took almost 6 years (Apr 2021) to raise first external round

 
 

Date

Round

$ Raised

Investors

04/27/2021

Series D

$50M

Tao Capital Partners, Pura Vida Investments, Northpond Ventures, ARCH Venture Partners, Applied Ventures, Ally Bridge Group

Date : 04/27/2021

Round: Series D

$ Raised: $50M

Investors: Tao Capital Partners, Pura Vida Investments, Northpond Ventures, ARCH Venture Partners, Applied Ventures, Ally Bridge Group

 

Investors

Interested in researching Ultivue?

We have plenty of data and we can help. Our deal sourcing platform can help you perform more research about Ultivue

Request a Demo - Deal Souring Platform

 
Jacques Corriveau


Jacques Corriveau
President and CEO

Richard Malabre CPA


Richard Malabre CPA
Chief Financial Officer

Ralf Jungmann


Ralf Jungmann
Co-Founder

 
 

Potential Customers

Interested in what they do or partnership?

Learn more about how they work

Schedule a Call w/ Ultivue